Is There an Association Between Pulmonary Embolism and the Use of PEG-Asparaginase in Children with Leukemia?

Creative Commons License

Yılmaz Orulluoğlu E., Kaya Z., Yazol M., Kirkiz Kayalı S., Koçak Ü.

EHOC 2023, İstanbul, Türkiye, 11 - 14 Ekim 2023, ss.43-44

  • Yayın Türü: Bildiri / Tam Metin Bildiri
  • Doi Numarası: 10.1016/j.htct.2023.09.077
  • Basıldığı Şehir: İstanbul
  • Basıldığı Ülke: Türkiye
  • Sayfa Sayıları: ss.43-44
  • Gazi Üniversitesi Adresli: Evet

Özet

We present two leukemic children who developed pulmonary thromboembolism (PTE) after using PEG-asparaginase.The first child, an eight-year-old boy, was diagnosed with T-acute lymphoblastic leukemia (ALL). The second child, a 6-year-old boy, was diagnosed with B-ALL.They developed PTE following induction phases of BFM protocol's.They were given PEG-asparaginase at a dose of 2500IU/m2. Heparin was succesfully used in both cases.Physician may consider prophylactic anticoagulants during induction.